Search

everythinglearnresearchcommunity

for

Search:↓

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

Women may need different blood pressure guidelines than men for heart disease prevention.

People often have negative attitudes toward those with alopecia, especially if it's severe or seen as a medical issue.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

People with alopecia areata are more likely to have other immune-related conditions.

Genetic variations greatly affect individual metabolism and can impact health and disease risk.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Photobiomodulation can improve hair density and thickness, but it's costly and needs more research.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Men generally face more severe COVID-19 outcomes than women, partly due to hormonal differences.

Scalp cooling is an effective and safe way to prevent hair loss from chemotherapy, with manageable side effects and low risk of scalp cancer.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Social media can help compare the effectiveness and safety of new arthritis medications.

Extracellular vesicles can help repair and regenerate tissues with less risk of rejection.

MK-5108 is safe and shows potential against tumors, especially alone.

Young transgender, gender diverse, and nonbinary people on spironolactone have a low risk of high potassium, so frequent monitoring may not be needed.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

The journal Anais Brasileiros de Dermatologia has grown significantly in influence and visibility over the past decade.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

Cepharanthine shows promise as a COVID-19 treatment.

People often have iron deficiency after weight-loss surgery, which can cause symptoms like hair loss and dizziness, and iron levels should be tested to diagnose it.

Monoclonal antibodies are often linked to alopecia areata cases.

CCCA involves immune response and metabolism issues, suggesting new treatment options.

Underactive bladder is hard to diagnose and treat, needing more research.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

Spironolactone may help women with hidradenitis suppurativa.